登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Multivariate analysis with 5-years survival in RGC patients.
Multivariate analysis with 5-years survival in RGC patients.
收藏
Figshare
2015-12-02 更新
2026-04-29 收录
视网膜神经节细胞
生存期分析
数据链接：
https://figshare.com/articles/dataset/_Multivariate_analysis_with_5_years_survival_in_RGC_patients_/1282088
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Multivariate analysis with 5-years survival in RGC patients.
应用场景：
创建时间：
2015-12-02
相关数据集
Sampling method for the counting of RGCs in Group 1 wholemounts (A) and Group 2 tissue sections (B).
视网膜神经节细胞
神经组织形态定量分析
RGC counts in retinal wholemounts were made in sampling boxes (0.260 mm2) along quadrant radii at 1.5 mm, 2.5 mm and 3.5 mm from the optic nerve head (white boxes; A). RGCs were counted in sections ov
NIAID Data Ecosystem
7
0
Univariate and multivariate analyses of prognostic factor for overall survival in 80 patients with pancreatic cancer.
胰腺癌预后
生存期分析
Univariate and multivariate analyses of prognostic factor for overall survival in 80 patients with pancreatic cancer.
NIAID Data Ecosystem
4
0
The median survival (95% CI) of different treatment modalities in IV CSCLC.
小细胞肺癌治疗
生存期分析
The median survival (95% CI) of different treatment modalities in IV CSCLC.
Figshare
2024-11-08 更新
3
0
Multiple regression analysis of prognostic factors for overall survival in the whole ALS patients.
ALS疾病预后
生存期分析
Multiple regression analysis of prognostic factors for overall survival in the whole ALS patients.
NIAID Data Ecosystem
6
0
Prospective observational study investigating the impact of treatment sequence using regorafenib and FTD/TPI for metastatic colorectal cancer on overall survival
结直肠癌靶向治疗
生存期分析
Primary outcome(s): Overall survival (OS) of sequential treatment with regorafenib-FTD/TPI
NIAID Data Ecosystem
3
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
